Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

HPV type 56 can hide in hair follicles even without visible warts.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

CD4+ skin cells may be precursors to basal cell carcinoma.

Alopecia areata involves unique activation of certain immune cells.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

PCFCL may have unrecognized subtypes and needs more research.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.